language_icon
EN
HI

Vaidya Sane Ayurved Laboratories Share price

MADHAVBAUG

259

6.00 (2.37%)
Last updated on 11 May, 2026 | 13:49 IST
Today's High

277.00

Today's Low

253.25

52 Week Low

128.00

52 Week High

335.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Vaidya Sane Ayurved Laboratories Chart

Vaidya Sane Ayurved Laboratories Share Key Metrics

Volume
5200.00
Market Cap
265.99 CR
LTQ@LTP
400@259.00
ATP
260.55
Var Margin
53.5 %
Circuit Range
202.4-303.6
Delivery %
76.47 %
Value
13.55 L
ASM/GSM
No
Market Lot
400

Summary

Vaidya Sane Ayurved Laboratories share price stands at ₹259 at 11 May, 2026 | 13:49. The stock Vaidya Sane Ayurved Laboratories intraday movement has stayed between ₹253.25 and ₹277.00, while on a 52-week basis it has fluctuated from ₹128.00 to ₹335.00.
In terms of trading activity, Vaidya Sane Ayurved Laboratories has recorded a volume of 5200 shares. The Vaidya Sane Ayurved Laboratories has a market cap of ₹10513450. The stock’s Average Traded Price (ATP) stands at ₹26055, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 400, 25900.
The Vaidya Sane Ayurved Laboratories operates within a circuit range of ₹202.4-303.6 – ₹202.4-303.6, with a Value of ₹13.55 L. The Delivery Percentage for the day is 76.47%. Additionally, Vaidya Sane Ayurved Laboratories currently falls under the No framework, and trades with a market lot size of 400.

Vaidya Sane Ayurved Laboratories Fundamentals

View More
P/E Ratio

37.27

P/B Ratio

4.25

Div. Yield

0

Sector P/E

56.71

Sector P/B

-15.83

Sec. Div. Yield

1.86

Vaidya Sane Ayurved Laboratories Resistance and Support

Pivot 250.77

Resistance

First Resistance

257.24

Second Resistance

261.47

Third Resistance

267.94

Support

First Support

246.54

Second Support

240.07

Third Support

235.84

Vaidya Sane Ayurved Laboratories Shareholding Pattern

View More
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

66.34%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

33.66%

Others

0%

Total Promoters
MAR '26
66.34%

Vaidya Sane Ayurved Laboratories Corporate Actions

DateAgenda
2026-05-15Audited Results
2025-11-05Quarterly Results

Vaidya Sane Ayurved Laboratories News

Vaidya Sane Ayurved Laboratories Limited

Vaidya Sane's Board of Directors will convene on May 15, 2026, to review and approve the audited standalone and consolidated annual financial results for the financial year ended March 2026.
May 07 2026 12:05:00

Vaidya Sane Ayurved Laboratories Limited (MADHAVBAUG)

Vaidya Sane Ayurved Laboratories confirms that its Annual Secretarial Compliance Report is not applicable for FY26. The company is exempt under Regulation 15(2) of SEBI (LODR) Regulations, 2015, as its securities are listed on the SME Exchange.
Apr 14 2026 13:04:00

Vaidya Sane Ayurved Laboratories Limited (MADHAVBAUG)

Vaidya Sane Ayurved Laboratories confirms that its Annual Secretarial Compliance Report is not applicable for FY26. The company is exempt under Regulation 15(2) of SEBI (LODR) Regulations, 2015, as its securities are listed on the SME Exchange.
Apr 14 2026 13:04:00
Read More

About Vaidya Sane Ayurved Laboratories

NSE : 8259  
BSE : 0  
ISIN : INE0JR301013  

Company was originally incorporated as a private limited company under the Companies Act 1956 pursuant to a certificate of incorporation issued by the Registrar of Companies Pune dated April 6 1999 with the name ‘Vaidya Sane Ayurved Laboratories Private Limited’. Subsequently our Company was converted into to a public limited company and the name of our Company was changed to ‘Vaidya Sane Ayurved Laboratories Limited’ by a special resolution passed on November 19 2021. A fresh Certificate of Incorporation consequent upon conversion was issued on November 25 2021 by the Registrar of Companies Pune.Major Events and Milestones 2006First Cardiac Prevention and Rehabilitation Hospital at Khopoli and opening of first Madhavbaug Clinic atDombivili Maharashtra2009 Setting up of inhouse research and development team at Thane.2012 First Cardiac Prevention and Rehabilitation Hospital at Nagpur.2013 Opening of 100th Madhavbaug Clinic at Kankavli Ratnagiri2014 Arogyam Hriday Sampada launched with a Mission to create awareness of heart disease.2015 Launch of therapies for risk factors such as Diabetes Obesity and Hypertension at Madhavbaug Clinics.2016 Disease wise diet kits introduced at Madhavbaug Clinics.Madhavbaug Institute of Preventive Cardiology established with MUHS.2017 Entered into the state of Madhya PradeshMadhavbaug Clinics received Frost and Sullivan’s 2017 India Best Practices Award.Randomised controlled trial by Madhavbaug published in Indian Heart Journal Official publication of Cardiological Society of India.2018 Madhavbaug Clinics enters in India Book of Records for Conducting GTT of 661 diabetic patients in single day at 13 different locations.Participated as main sponsor of World Ayurved Congress 2018 held at Ahmedabad.Opening of 200th Madhavbaug Clinic at Nanded MaharashtraEntered into the state of Uttar Pradesh and Gujarat2019 Entered into the state of DelhiMadhavbaug introduced research based heart blockage management program.Achieved new registrations of over 90000 patients and more than 27000 stress tests conducted and over 300000 panchkarma procedures performed.2020 Launch of MIB Pulse Mobile Application for patient engagement.Entered into the state of Karnataka2021 MIB Pulse Mobile Application achieved over 100000 downloadsOpening of 250th Madhavbaug Clinic at Vashi.Entered into the state of ChhattisgarhResearch trial on one year follow-up of Diabetes patients treated by Madhavbaug published in Journal of Association of Physicians of India.

Read More

Vaidya Sane Ayurved Laboratories Management

NamePosition
Rohit Madhav SaneManaging Director & Chief Executive Officer
Vidyut B GhagWhole Time Director
View More

Vaidya Sane Ayurved Laboratories FAQs

The Buying Price of Vaidya Sane Ayurved Laboratories share is 259 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Vaidya Sane Ayurved Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Vaidya Sane Ayurved Laboratories, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Vaidya Sane Ayurved Laboratories shares is 37.27. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Vaidya Sane Ayurved Laboratories shares is 4.25. Useful to assess the stock's value relative to its book value.

To assess Vaidya Sane Ayurved Laboratories’s valuation compare Sector P/E, P/B which are 56.71 & -15.83 with sector averages, along with growth rates and financial metrics.

The Market Cap of Vaidya Sane Ayurved Laboratories is 265.99 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Vaidya Sane Ayurved Laboratories share price is 335.00 & 128.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Vaidya Sane Ayurved Laboratories belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost